nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C8—Mometasone—systemic scleroderma	0.168	0.289	CbGbCtD
Thioridazine—CYP1A2—Pentoxifylline—systemic scleroderma	0.088	0.151	CbGbCtD
Thioridazine—CYP1A2—Leflunomide—systemic scleroderma	0.0839	0.144	CbGbCtD
Thioridazine—CYP2C9—Leflunomide—systemic scleroderma	0.0756	0.13	CbGbCtD
Thioridazine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.067	0.115	CbGbCtD
Thioridazine—CYP2D6—Captopril—systemic scleroderma	0.0543	0.0933	CbGbCtD
Thioridazine—CYP2C19—Prednisone—systemic scleroderma	0.0449	0.0772	CbGbCtD
Thioridazine—CYP2C9—cardial valve—systemic scleroderma	0.023	0.193	CbGeAlD
Thioridazine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0174	0.146	CbGeAlD
Thioridazine—HTR7—pulmonary artery—systemic scleroderma	0.0123	0.103	CbGeAlD
Thioridazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0109	0.0908	CbGeAlD
Thioridazine—HTR2A—pulmonary artery—systemic scleroderma	0.00768	0.0643	CbGeAlD
Thioridazine—HTR7—artery—systemic scleroderma	0.00457	0.0382	CbGeAlD
Thioridazine—HTR7—endothelium—systemic scleroderma	0.00386	0.0323	CbGeAlD
Thioridazine—HTR7—blood vessel—systemic scleroderma	0.00356	0.0298	CbGeAlD
Thioridazine—HTR2A—artery—systemic scleroderma	0.00285	0.0238	CbGeAlD
Thioridazine—HTR2A—endothelium—systemic scleroderma	0.00241	0.0201	CbGeAlD
Thioridazine—HTR2A—blood vessel—systemic scleroderma	0.00222	0.0186	CbGeAlD
Thioridazine—HTR7—connective tissue—systemic scleroderma	0.00182	0.0153	CbGeAlD
Thioridazine—HTR7—smooth muscle tissue—systemic scleroderma	0.00167	0.014	CbGeAlD
Thioridazine—HRH1—connective tissue—systemic scleroderma	0.00136	0.0114	CbGeAlD
Thioridazine—ADRA2A—connective tissue—systemic scleroderma	0.00134	0.0112	CbGeAlD
Thioridazine—HTR7—digestive system—systemic scleroderma	0.00132	0.011	CbGeAlD
Thioridazine—CYP2C19—digestive system—systemic scleroderma	0.00129	0.0108	CbGeAlD
Thioridazine—HTR7—tendon—systemic scleroderma	0.00125	0.0105	CbGeAlD
Thioridazine—HRH1—smooth muscle tissue—systemic scleroderma	0.00125	0.0104	CbGeAlD
Thioridazine—Amenorrhoea—Prednisone—systemic scleroderma	0.00122	0.00409	CcSEcCtD
Thioridazine—Confusional state—Pentoxifylline—systemic scleroderma	0.00121	0.00406	CcSEcCtD
Thioridazine—Oedema—Pentoxifylline—systemic scleroderma	0.0012	0.00402	CcSEcCtD
Thioridazine—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.0012	0.004	CcSEcCtD
Thioridazine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00118	0.00394	CcSEcCtD
Thioridazine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00117	0.00393	CcSEcCtD
Thioridazine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00116	0.00389	CcSEcCtD
Thioridazine—Hepatotoxicity—Methotrexate—systemic scleroderma	0.00116	0.00389	CcSEcCtD
Thioridazine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00116	0.00389	CcSEcCtD
Thioridazine—Angioedema—Mometasone—systemic scleroderma	0.00116	0.00389	CcSEcCtD
Thioridazine—Jaundice—Leflunomide—systemic scleroderma	0.00115	0.00384	CcSEcCtD
Thioridazine—Weight increased—Mycophenolic acid—systemic scleroderma	0.00115	0.00384	CcSEcCtD
Thioridazine—Anorexia—Pentoxifylline—systemic scleroderma	0.00114	0.00383	CcSEcCtD
Thioridazine—HTR2A—connective tissue—systemic scleroderma	0.00114	0.00952	CbGeAlD
Thioridazine—Asthma—Lisinopril—systemic scleroderma	0.00113	0.0038	CcSEcCtD
Thioridazine—Eosinophilia—Lisinopril—systemic scleroderma	0.00112	0.00376	CcSEcCtD
Thioridazine—Hypotension—Pentoxifylline—systemic scleroderma	0.00112	0.00376	CcSEcCtD
Thioridazine—Psychotic disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00376	CcSEcCtD
Thioridazine—Sweating increased—Lisinopril—systemic scleroderma	0.0011	0.0037	CcSEcCtD
Thioridazine—HTR7—lung—systemic scleroderma	0.0011	0.00921	CbGeAlD
Thioridazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.0011	0.00368	CcSEcCtD
Thioridazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00109	0.00366	CcSEcCtD
Thioridazine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00366	CcSEcCtD
Thioridazine—Pancytopenia—Lisinopril—systemic scleroderma	0.00108	0.00361	CcSEcCtD
Thioridazine—Somnolence—Pentoxifylline—systemic scleroderma	0.00107	0.00358	CcSEcCtD
Thioridazine—Vision blurred—Captopril—systemic scleroderma	0.00105	0.00352	CcSEcCtD
Thioridazine—CYP1A2—digestive system—systemic scleroderma	0.00105	0.0088	CbGeAlD
Thioridazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00105	0.00351	CcSEcCtD
Thioridazine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00104	0.0035	CcSEcCtD
Thioridazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.00104	0.00871	CbGeAlD
Thioridazine—DRD2—lung—systemic scleroderma	0.00104	0.00871	CbGeAlD
Thioridazine—Oedema peripheral—Leflunomide—systemic scleroderma	0.00104	0.00348	CcSEcCtD
Thioridazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00103	0.00347	CcSEcCtD
Thioridazine—Weight increased—Lisinopril—systemic scleroderma	0.00103	0.00346	CcSEcCtD
Thioridazine—Anaemia—Captopril—systemic scleroderma	0.00103	0.00345	CcSEcCtD
Thioridazine—Constipation—Pentoxifylline—systemic scleroderma	0.00103	0.00344	CcSEcCtD
Thioridazine—Angioedema—Captopril—systemic scleroderma	0.00102	0.00341	CcSEcCtD
Thioridazine—Arrhythmia—Azathioprine—systemic scleroderma	0.000999	0.00335	CcSEcCtD
Thioridazine—CYP2C9—digestive system—systemic scleroderma	0.000998	0.00835	CbGeAlD
Thioridazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000993	0.00333	CcSEcCtD
Thioridazine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000992	0.00332	CcSEcCtD
Thioridazine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00099	0.00332	CcSEcCtD
Thioridazine—Anorexia—Mometasone—systemic scleroderma	0.000988	0.00331	CcSEcCtD
Thioridazine—Jaundice—Lisinopril—systemic scleroderma	0.000985	0.0033	CcSEcCtD
Thioridazine—HRH1—digestive system—systemic scleroderma	0.000984	0.00824	CbGeAlD
Thioridazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000949	0.00318	CcSEcCtD
Thioridazine—CYP2E1—digestive system—systemic scleroderma	0.000945	0.00791	CbGeAlD
Thioridazine—Arrhythmia—Leflunomide—systemic scleroderma	0.000943	0.00316	CcSEcCtD
Thioridazine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000943	0.00316	CcSEcCtD
Thioridazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000943	0.00316	CcSEcCtD
Thioridazine—HRH1—tendon—systemic scleroderma	0.000936	0.00784	CbGeAlD
Thioridazine—Hyperkinesia—Prednisone—systemic scleroderma	0.000936	0.00313	CcSEcCtD
Thioridazine—Mental disorder—Leflunomide—systemic scleroderma	0.000925	0.0031	CcSEcCtD
Thioridazine—ADRA2A—tendon—systemic scleroderma	0.00092	0.0077	CbGeAlD
Thioridazine—Confusional state—Captopril—systemic scleroderma	0.000918	0.00307	CcSEcCtD
Thioridazine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00303	CcSEcCtD
Thioridazine—Decreased appetite—Mometasone—systemic scleroderma	0.000901	0.00302	CcSEcCtD
Thioridazine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.0009	0.00301	CcSEcCtD
Thioridazine—CYP2E1—tendon—systemic scleroderma	0.0009	0.00753	CbGeAlD
Thioridazine—Anaemia—Azathioprine—systemic scleroderma	0.0009	0.00301	CcSEcCtD
Thioridazine—Oedema peripheral—Lisinopril—systemic scleroderma	0.000894	0.00299	CcSEcCtD
Thioridazine—Thrombocytopenia—Captopril—systemic scleroderma	0.000891	0.00299	CcSEcCtD
Thioridazine—Tachycardia—Captopril—systemic scleroderma	0.000888	0.00298	CcSEcCtD
Thioridazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000885	0.00296	CcSEcCtD
Thioridazine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000882	0.00296	CcSEcCtD
Thioridazine—CYP1A2—lung—systemic scleroderma	0.000878	0.00735	CbGeAlD
Thioridazine—Leukopenia—Azathioprine—systemic scleroderma	0.000871	0.00292	CcSEcCtD
Thioridazine—Anorexia—Captopril—systemic scleroderma	0.000868	0.00291	CcSEcCtD
Thioridazine—Vision blurred—Leflunomide—systemic scleroderma	0.000866	0.0029	CcSEcCtD
Thioridazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000863	0.00289	CcSEcCtD
Thioridazine—Hypotension—Captopril—systemic scleroderma	0.00085	0.00285	CcSEcCtD
Thioridazine—Anaemia—Leflunomide—systemic scleroderma	0.00085	0.00285	CcSEcCtD
Thioridazine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000842	0.00282	CcSEcCtD
Thioridazine—Angioedema—Leflunomide—systemic scleroderma	0.00084	0.00281	CcSEcCtD
Thioridazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000826	0.00277	CcSEcCtD
Thioridazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000826	0.00277	CcSEcCtD
Thioridazine—Leukopenia—Leflunomide—systemic scleroderma	0.000823	0.00276	CcSEcCtD
Thioridazine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000822	0.00275	CcSEcCtD
Thioridazine—HTR2A—digestive system—systemic scleroderma	0.000822	0.00688	CbGeAlD
Thioridazine—HRH1—lung—systemic scleroderma	0.000822	0.00688	CbGeAlD
Thioridazine—Tremor—Mycophenolic acid—systemic scleroderma	0.000821	0.00275	CcSEcCtD
Thioridazine—Body temperature increased—Mometasone—systemic scleroderma	0.000819	0.00274	CcSEcCtD
Thioridazine—Arrhythmia—Lisinopril—systemic scleroderma	0.00081	0.00272	CcSEcCtD
Thioridazine—Anaemia—Mycophenolic acid—systemic scleroderma	0.00081	0.00271	CcSEcCtD
Thioridazine—Somnolence—Captopril—systemic scleroderma	0.000809	0.00271	CcSEcCtD
Thioridazine—ADRA2A—lung—systemic scleroderma	0.000807	0.00676	CbGeAlD
Thioridazine—Agitation—Mycophenolic acid—systemic scleroderma	0.000806	0.0027	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.000802	0.00269	CcSEcCtD
Thioridazine—Mental disorder—Lisinopril—systemic scleroderma	0.000795	0.00266	CcSEcCtD
Thioridazine—Lethargy—Prednisone—systemic scleroderma	0.000795	0.00266	CcSEcCtD
Thioridazine—Decreased appetite—Captopril—systemic scleroderma	0.000791	0.00265	CcSEcCtD
Thioridazine—Erythema—Lisinopril—systemic scleroderma	0.00079	0.00265	CcSEcCtD
Thioridazine—CYP2E1—lung—systemic scleroderma	0.00079	0.00661	CbGeAlD
Thioridazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000785	0.00263	CcSEcCtD
Thioridazine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000783	0.00262	CcSEcCtD
Thioridazine—HTR2A—tendon—systemic scleroderma	0.000782	0.00655	CbGeAlD
Thioridazine—Constipation—Captopril—systemic scleroderma	0.000778	0.00261	CcSEcCtD
Thioridazine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000778	0.00261	CcSEcCtD
Thioridazine—Vomiting—Pentoxifylline—systemic scleroderma	0.000764	0.00256	CcSEcCtD
Thioridazine—Psychotic disorder—Prednisone—systemic scleroderma	0.000761	0.00255	CcSEcCtD
Thioridazine—Rash—Pentoxifylline—systemic scleroderma	0.000757	0.00254	CcSEcCtD
Thioridazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000757	0.00253	CcSEcCtD
Thioridazine—Headache—Pentoxifylline—systemic scleroderma	0.000752	0.00252	CcSEcCtD
Thioridazine—Feeling abnormal—Captopril—systemic scleroderma	0.00075	0.00251	CcSEcCtD
Thioridazine—CYP2D6—digestive system—systemic scleroderma	0.000749	0.00627	CbGeAlD
Thioridazine—Vision blurred—Lisinopril—systemic scleroderma	0.000744	0.00249	CcSEcCtD
Thioridazine—Hypotension—Azathioprine—systemic scleroderma	0.000742	0.00249	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—systemic scleroderma	0.000741	0.00248	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—systemic scleroderma	0.000741	0.00248	CcSEcCtD
Thioridazine—Tremor—Lisinopril—systemic scleroderma	0.00074	0.00248	CcSEcCtD
Thioridazine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000734	0.00246	CcSEcCtD
Thioridazine—Tachycardia—Leflunomide—systemic scleroderma	0.000732	0.00245	CcSEcCtD
Thioridazine—Anaemia—Lisinopril—systemic scleroderma	0.00073	0.00245	CcSEcCtD
Thioridazine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000725	0.00243	CcSEcCtD
Thioridazine—Angioedema—Lisinopril—systemic scleroderma	0.000722	0.00242	CcSEcCtD
Thioridazine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000722	0.00242	CcSEcCtD
Thioridazine—Body temperature increased—Captopril—systemic scleroderma	0.000719	0.00241	CcSEcCtD
Thioridazine—Oedema—Mycophenolic acid—systemic scleroderma	0.000716	0.0024	CcSEcCtD
Thioridazine—Anorexia—Leflunomide—systemic scleroderma	0.000715	0.0024	CcSEcCtD
Thioridazine—Nausea—Pentoxifylline—systemic scleroderma	0.000713	0.00239	CcSEcCtD
Thioridazine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00238	CcSEcCtD
Thioridazine—Diarrhoea—Mometasone—systemic scleroderma	0.000709	0.00238	CcSEcCtD
Thioridazine—Leukopenia—Lisinopril—systemic scleroderma	0.000707	0.00237	CcSEcCtD
Thioridazine—Hypotension—Leflunomide—systemic scleroderma	0.000701	0.00235	CcSEcCtD
Thioridazine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000701	0.00235	CcSEcCtD
Thioridazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000698	0.00234	CcSEcCtD
Thioridazine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00233	CcSEcCtD
Thioridazine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000692	0.00232	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00069	0.00231	CcSEcCtD
Thioridazine—HTR2A—lung—systemic scleroderma	0.000686	0.00574	CbGeAlD
Thioridazine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000682	0.00229	CcSEcCtD
Thioridazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000669	0.00224	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—systemic scleroderma	0.000664	0.00223	CcSEcCtD
Thioridazine—Vomiting—Mometasone—systemic scleroderma	0.000659	0.00221	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—systemic scleroderma	0.000656	0.0022	CcSEcCtD
Thioridazine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000655	0.00219	CcSEcCtD
Thioridazine—Rash—Mometasone—systemic scleroderma	0.000653	0.00219	CcSEcCtD
Thioridazine—Dermatitis—Mometasone—systemic scleroderma	0.000653	0.00219	CcSEcCtD
Thioridazine—Decreased appetite—Leflunomide—systemic scleroderma	0.000652	0.00218	CcSEcCtD
Thioridazine—Confusional state—Lisinopril—systemic scleroderma	0.00065	0.00218	CcSEcCtD
Thioridazine—Headache—Mometasone—systemic scleroderma	0.000649	0.00217	CcSEcCtD
Thioridazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000648	0.00217	CcSEcCtD
Thioridazine—Oedema—Lisinopril—systemic scleroderma	0.000645	0.00216	CcSEcCtD
Thioridazine—Constipation—Leflunomide—systemic scleroderma	0.000641	0.00215	CcSEcCtD
Thioridazine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00214	CcSEcCtD
Thioridazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000636	0.00213	CcSEcCtD
Thioridazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00213	CcSEcCtD
Thioridazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000632	0.00212	CcSEcCtD
Thioridazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000631	0.00211	CcSEcCtD
Thioridazine—Tachycardia—Lisinopril—systemic scleroderma	0.000629	0.00211	CcSEcCtD
Thioridazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000628	0.0021	CcSEcCtD
Thioridazine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000623	0.00209	CcSEcCtD
Thioridazine—Diarrhoea—Captopril—systemic scleroderma	0.000623	0.00209	CcSEcCtD
Thioridazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000622	0.00208	CcSEcCtD
Thioridazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000619	0.00207	CcSEcCtD
Thioridazine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000618	0.00207	CcSEcCtD
Thioridazine—Nausea—Mometasone—systemic scleroderma	0.000616	0.00206	CcSEcCtD
Thioridazine—Anorexia—Lisinopril—systemic scleroderma	0.000614	0.00206	CcSEcCtD
Thioridazine—Weight increased—Prednisone—systemic scleroderma	0.000613	0.00205	CcSEcCtD
Thioridazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000612	0.00205	CcSEcCtD
Thioridazine—Hypotension—Lisinopril—systemic scleroderma	0.000602	0.00202	CcSEcCtD
Thioridazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000593	0.00199	CcSEcCtD
Thioridazine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00059	0.00198	CcSEcCtD
Thioridazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000585	0.00196	CcSEcCtD
Thioridazine—Vomiting—Captopril—systemic scleroderma	0.000579	0.00194	CcSEcCtD
Thioridazine—Rash—Captopril—systemic scleroderma	0.000574	0.00192	CcSEcCtD
Thioridazine—Dermatitis—Captopril—systemic scleroderma	0.000573	0.00192	CcSEcCtD
Thioridazine—Somnolence—Lisinopril—systemic scleroderma	0.000573	0.00192	CcSEcCtD
Thioridazine—Headache—Captopril—systemic scleroderma	0.00057	0.00191	CcSEcCtD
Thioridazine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00191	CcSEcCtD
Thioridazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000566	0.0019	CcSEcCtD
Thioridazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00189	CcSEcCtD
Thioridazine—Asthma—Methotrexate—systemic scleroderma	0.000563	0.00188	CcSEcCtD
Thioridazine—Decreased appetite—Lisinopril—systemic scleroderma	0.00056	0.00188	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—systemic scleroderma	0.000557	0.00187	CcSEcCtD
Thioridazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000553	0.00185	CcSEcCtD
Thioridazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000553	0.00185	CcSEcCtD
Thioridazine—Constipation—Lisinopril—systemic scleroderma	0.000551	0.00185	CcSEcCtD
Thioridazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000551	0.00185	CcSEcCtD
Thioridazine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000546	0.00183	CcSEcCtD
Thioridazine—Diarrhoea—Azathioprine—systemic scleroderma	0.000543	0.00182	CcSEcCtD
Thioridazine—Nausea—Captopril—systemic scleroderma	0.000541	0.00181	CcSEcCtD
Thioridazine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000538	0.0018	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—systemic scleroderma	0.000534	0.00179	CcSEcCtD
Thioridazine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000531	0.00178	CcSEcCtD
Thioridazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000528	0.00177	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000514	0.00172	CcSEcCtD
Thioridazine—Diarrhoea—Leflunomide—systemic scleroderma	0.000513	0.00172	CcSEcCtD
Thioridazine—Body temperature increased—Lisinopril—systemic scleroderma	0.00051	0.00171	CcSEcCtD
Thioridazine—Vomiting—Azathioprine—systemic scleroderma	0.000505	0.00169	CcSEcCtD
Thioridazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000502	0.00168	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—systemic scleroderma	0.000502	0.00168	CcSEcCtD
Thioridazine—Rash—Azathioprine—systemic scleroderma	0.000501	0.00168	CcSEcCtD
Thioridazine—Dermatitis—Azathioprine—systemic scleroderma	0.0005	0.00168	CcSEcCtD
Thioridazine—Headache—Azathioprine—systemic scleroderma	0.000498	0.00167	CcSEcCtD
Thioridazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00164	CcSEcCtD
Thioridazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00049	0.00164	CcSEcCtD
Thioridazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000483	0.00162	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—systemic scleroderma	0.000481	0.00161	CcSEcCtD
Thioridazine—Vomiting—Leflunomide—systemic scleroderma	0.000477	0.0016	CcSEcCtD
Thioridazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000475	0.00159	CcSEcCtD
Thioridazine—Rash—Leflunomide—systemic scleroderma	0.000473	0.00158	CcSEcCtD
Thioridazine—Dermatitis—Leflunomide—systemic scleroderma	0.000473	0.00158	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—systemic scleroderma	0.000472	0.00158	CcSEcCtD
Thioridazine—Nausea—Azathioprine—systemic scleroderma	0.000472	0.00158	CcSEcCtD
Thioridazine—Headache—Leflunomide—systemic scleroderma	0.00047	0.00157	CcSEcCtD
Thioridazine—Erythema—Prednisone—systemic scleroderma	0.000469	0.00157	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000468	0.00157	CcSEcCtD
Thioridazine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000465	0.00156	CcSEcCtD
Thioridazine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000455	0.00152	CcSEcCtD
Thioridazine—Rash—Mycophenolic acid—systemic scleroderma	0.000451	0.00151	CcSEcCtD
Thioridazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000451	0.00151	CcSEcCtD
Thioridazine—Headache—Mycophenolic acid—systemic scleroderma	0.000448	0.0015	CcSEcCtD
Thioridazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000446	0.0015	CcSEcCtD
Thioridazine—Nausea—Leflunomide—systemic scleroderma	0.000446	0.00149	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—systemic scleroderma	0.000442	0.00148	CcSEcCtD
Thioridazine—Diarrhoea—Lisinopril—systemic scleroderma	0.000441	0.00148	CcSEcCtD
Thioridazine—Anaemia—Prednisone—systemic scleroderma	0.000434	0.00145	CcSEcCtD
Thioridazine—Agitation—Prednisone—systemic scleroderma	0.000431	0.00144	CcSEcCtD
Thioridazine—Angioedema—Prednisone—systemic scleroderma	0.000429	0.00144	CcSEcCtD
Thioridazine—Nausea—Mycophenolic acid—systemic scleroderma	0.000425	0.00142	CcSEcCtD
Thioridazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00139	CcSEcCtD
Thioridazine—Vomiting—Lisinopril—systemic scleroderma	0.00041	0.00137	CcSEcCtD
Thioridazine—Rash—Lisinopril—systemic scleroderma	0.000406	0.00136	CcSEcCtD
Thioridazine—Dermatitis—Lisinopril—systemic scleroderma	0.000406	0.00136	CcSEcCtD
Thioridazine—Headache—Lisinopril—systemic scleroderma	0.000404	0.00135	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—systemic scleroderma	0.000395	0.00132	CcSEcCtD
Thioridazine—Erythema—Methotrexate—systemic scleroderma	0.000392	0.00131	CcSEcCtD
Thioridazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00129	CcSEcCtD
Thioridazine—Nausea—Lisinopril—systemic scleroderma	0.000383	0.00128	CcSEcCtD
Thioridazine—Oedema—Prednisone—systemic scleroderma	0.000383	0.00128	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—systemic scleroderma	0.000374	0.00125	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00037	0.00124	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—systemic scleroderma	0.000369	0.00124	CcSEcCtD
Thioridazine—Anorexia—Prednisone—systemic scleroderma	0.000365	0.00122	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—systemic scleroderma	0.000362	0.00121	CcSEcCtD
Thioridazine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000359	0.0012	CcSEcCtD
Thioridazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00119	CcSEcCtD
Thioridazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000356	0.00119	CcSEcCtD
Thioridazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00119	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—systemic scleroderma	0.000351	0.00118	CcSEcCtD
Thioridazine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00112	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—systemic scleroderma	0.000333	0.00111	CcSEcCtD
Thioridazine—Constipation—Prednisone—systemic scleroderma	0.000327	0.0011	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—systemic scleroderma	0.000323	0.00108	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisone—systemic scleroderma	0.000315	0.00106	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000313	0.00105	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000309	0.00104	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—systemic scleroderma	0.000305	0.00102	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—systemic scleroderma	0.000303	0.00101	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—systemic scleroderma	0.000299	0.001	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—systemic scleroderma	0.000284	0.000953	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000282	0.000945	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000278	0.000932	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000264	0.000883	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—systemic scleroderma	0.000262	0.000877	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000253	0.000847	CcSEcCtD
Thioridazine—Vomiting—Prednisone—systemic scleroderma	0.000243	0.000815	CcSEcCtD
Thioridazine—Rash—Prednisone—systemic scleroderma	0.000241	0.000809	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—systemic scleroderma	0.000241	0.000808	CcSEcCtD
Thioridazine—Headache—Prednisone—systemic scleroderma	0.00024	0.000803	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000236	0.00079	CcSEcCtD
Thioridazine—Nausea—Prednisone—systemic scleroderma	0.000227	0.000762	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000219	0.000733	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—systemic scleroderma	0.000203	0.000681	CcSEcCtD
Thioridazine—Rash—Methotrexate—systemic scleroderma	0.000202	0.000676	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—systemic scleroderma	0.000202	0.000675	CcSEcCtD
Thioridazine—Headache—Methotrexate—systemic scleroderma	0.0002	0.000671	CcSEcCtD
Thioridazine—Nausea—Methotrexate—systemic scleroderma	0.00019	0.000637	CcSEcCtD
